« Previous
Next »
Experimental Hematology
Volume 34, Issue 10
, Pages 1333-1343
, October 2006
Stable gene transfer to human CD34+ hematopoietic cells using the Sleeping Beauty transposon
References
- . Gene therapy for genetic and haematological disorders and immunodeficiencies. J Intern Med. 2001;249:379–390
- . Therapeutic applications for hematopoietic stem cell gene transfer. Nat Immunol. 2002;3:318–321
- . Gene therapy for inherited disorders of hematopoietic cells. Hematol J. 2004;5:103–111
- . Site-specific genomic strategies for gene therapy. Curr Opin Mol Ther. 2003;5:376–382
- . Phage integrases: biology and applications. J Mol Biol. 2004;335:667–678
- . Sleeping Beauty transposition: biology and applications for molecular therapy. Mol Ther. 2004;9:147–156
- . Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell. 1997;91:501–510
- . The Tc1-mariner superfamily of transposons in animals. J Insect Physiol. 1995;41:99–105
- . Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet. 2000;25:35–41
- Efficient chromosomal transposition of a Tc1/mariner-like transposon Sleeping Beauty in mice. Proc Natl Acad Sci U S A. 2001;98:9191–9196
- In vivo correction of murine tyrosemia type I by DNA-mediated transposition. Mol Ther. 2002;6:759–769
- . Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer. Gene Ther. 2003;10:1099–1104
- . Endothelial targeting of the Sleeping Beauty transposon within lung. Mol Ther. 2004;13:97–105
- Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther. 2003;8:501–507
- Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. Blood. 2006;107:483–491
- . Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci U S A. 1998;95:10769–10773
- Real-time in vivo imaging of stem cells following transgenesis by transposition. Mol Ther. 2005;12:42–48
- Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection. J Immunother. 2002;25:445–454
- . Liposome-mediated functional expression of multiple drug resistance gene in human bone marrow CD34+ cells. J Huazhong Univ Sci Technolog Med Sci. 2004;24:214–215, 235
- Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation. Bone Marrow Transplant. 2001;27:1201–1209
- . High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells. Stem Cells. 2001;19:492–499
- . Optimisation of transfection conditions of CD34+ hematopoietic cells derived from human umbilical cord blood. Acta Biochim Pol. 2002;49:625–632
- Gene transfer in purified human hematopoietic peripheral-blood stem cells by means of electroporation without prestimulation. J Lab Clin Med. 2003;141:138–149
- RNA-based gene transfer for adult stem cells and T cells. Leukemia. 2004;18:1898–1902
- New non-viral method for gene transfer into primary cells. Methods. 2004;33:151–163
- . A functional comparison of CD34+ CD38- cells in cord blood and bone marrow. Blood. 1995;10:3745–3753
- . Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J Virol. 1995;69:748–755
- Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol. 1997;71:9466–9474
- . The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation. Gene. 1984;32:481–485
- . A functional comparison of CD34+CD38− cells in cord blood and bone marrow. Blood. 1995;86:3745–3753
- . Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells. Mol Ther. 2003;7:325–333
- . Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells. Mol Cell Biol. 2003;23:8505–8518
- . The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. Nucleic Acid Research. 2003;31:2313–2322
- . Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol. 2000;302:93–102
- . Mutational analysis of the N-terminal DNA-binding domain of Sleeping Beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells. Mol Cell Biol. 2004;24:9239–9247
- . Development of hyperactive Sleeping Beauty transposon vectors by mutational analysis. Mol Ther. 2004;9:292–304
- . Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol Ther. 2005;12:1148–1156
- Transient gene expression by non-integrating lentiviral (NIL) vectors. Mol Ther. 2006;13:1121–1132
- . High-resolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol. 2005;25:2085–2094
- Target-site preferences of Sleeping Beauty transposons. J Mol Biol. 2005;346:161–173
PII: S0301-472X(06)00495-4
doi: 10.1016/j.exphem.2006.05.023
© 2006 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Experimental Hematology
Volume 34, Issue 10
, Pages 1333-1343
, October 2006
